Get started
Author

Krzysztof Szczerbowski

Observed name: Szczerbowski, Krzysztof
Institution: Centrum Onkologii
ORCID: 0000-0003-0722-7139
Observed ORCID: 0000-0003-0722-7139
OpenAlex ID: A5072489285
The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Biomedicines · 95
PDF
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Medical Oncology · 38
PDF
CDK9: Therapeutic Perspective in HCC Therapy
2020 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Current Cancer Drug Targets · 16
The Prognostic Role of CDK9 in Bladder Cancer
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Cancers · 9
PDF
Mechanisms of SARS-CoV-2 Placental Transmission
2023 · Karol Gostomczyk, Jędrzej Borowczak, et al. · Archivum Immunologiae et Therapiae Experimentalis · 8
PDF
SARS-CoV-2 Infection during Delivery Causes Histopathological Changes in the Placenta
2024 · Jędrzej Borowczak, Agnieszka Gąsiorek-Kwiatkowska, et al. · Diseases · 6
TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma
2022 · Adam Kowalewski, Damian Jaworski, et al. · International Journal of Molecular Sciences · 6
PDF
The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma
2022 · Jędrzej Borowczak, Krzysztof Szczerbowski, et al. · Clinical & Translational Oncology · 4
PDF
High MAL2 expression predicts shorter survival in women with triple-negative breast cancer
2024 · Jędrzej Borowczak, Marek Zdrenka, et al. · Clinical & Translational Oncology · 3
Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy
2021 · Anna Kasperska, Jędrzej Borowczak, et al. · Current Cancer Drug Targets · 2
Works count: 11
Citation count: 187
H-index: 6
I10-index: 3
Year
Topic
Type